← Browse by Condition
Medical Condition
bipolar i disorder
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4, Phase 3, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for bipolar i disorder sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — bipolar i disorder Clinical Trials
How many clinical trials are currently recruiting for bipolar i disorder?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for bipolar i disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bipolar i disorder?
bipolar i disorder research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bipolar i disorder clinical trial?
Eligibility criteria for bipolar i disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05648591 Phase 4
Recruiting
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Enrollment
100 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
NCT04777357 Phase 3
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Enrollment
380 pts
Location
United States, Puert...
Sponsor
AbbVie
NCT06560957
Recruiting
SYNCED - SYNChronized Eating in Bipolar Depression Study
Enrollment
40 pts
Location
Canada
Sponsor
University of Ottawa
NCT07540338 Phase 1, Phase 2
Recruiting
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
Enrollment
20 pts
Location
United States
Sponsor
Alzamend Neuro, Inc.
NCT05427123
Recruiting
Children's Bipolar Network Treatment Trial I
Enrollment
80 pts
Location
United States
Sponsor
University of California, Los ...
NCT07172516 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Enrollment
400 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology